Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIOP | ||||
| Company | Fortress Biotech Inc 9.375% Series A Cumulativ | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 13.78 | ||||
| High | 14.36 | ||||
| Low | 13.50 | ||||
| Latest | 14.17 | ||||
| Change | +0.76 | ||||
| % Change | +5.67% | ||||
| Volume | 18,250 | ||||
| 20-Day Average Volume | 10,016 | ||||
| Previous Close | 13.41 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 13.53 | ||||
| 20-Day Raw Stochastic | 92.28% | ||||
| 20-Day Relative Strength | 62.22 | ||||
| Weighted Alpha | +100.59 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 80% Buy | ||||
| Last Month's Opinion | 88% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.43% since 04/17/26 | ||||
| Low | 12.93 on 04/20/26 | ||||
| High | 14.36 on 04/24/26 | ||||
| 1-Month | |||||
| %Chg | +7.43% since 03/24/26 | ||||
| Low | 12.75 on 03/26/26 | ||||
| High | 14.36 on 04/24/26 | ||||
| 3-Month | |||||
| %Chg | +12.12% since 01/23/26 | ||||
| Low | 10.62 on 02/20/26 | ||||
| High | 14.64 on 03/02/26 | ||||
| 6-Month | |||||
| %Chg | +105.45% since 10/24/25 | ||||
| Low | 6.27 on 11/14/25 | ||||
| High | 14.64 on 03/02/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 63,262,000 | ||||
| Annual Net Income | 6,815,000 | ||||
| Last Quarter Sales | 16,079,000 | ||||
| Last Quarter Net Income | -3,937,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||